SCHEMBL25663198

SCHEMBL25663198

c1ccc2c(c1)sc1nc(-c3ccc(N(c4ccc(-c5ccc6ccncc6n5)cc4)c4ccc(-c5ccc6ccncc6n5)cc4)cc3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.38
▸ RAB9A P51151 8/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ AR P10275 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ MINK1 Q8N4C8 1/20 0.38
▸ TNIK Q9UKE5 1/20 0.38
▸ CDC7 O00311 1/20 0.34
▸ LIMK1 P53667 3/20 0.33
▸ CYP11B1 P15538 1/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ MAPT P10636 3/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ NFKB1 P19838 2/20 0.32
▸ NFKB2 Q00653 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663194 0.91 NPC1 (0.38) NPC1RAB9ACYP3A4ARCYP1A2
SCHEMBL25663205 0.87 PDGFRB (0.39) MAP4K4MINK1TNIKLIMK1CYP11B1
SCHEMBL25663184 0.87 RAB9A (0.44) NPC1RAB9ACYP3A4ARCYP1A2
SCHEMBL25663192 0.87 PRKCZ (0.40) NPC1RAB9ALIMK1CYP11B1MEN1
SCHEMBL25663187 0.87 TDO2 (0.39) NPC1RAB9AMAP4K4CDC7LIMK1
SCHEMBL25461926 0.87 MAP4K4 (0.39) NPC1RAB9ACYP3A4ARCYP1A2
SCHEMBL25663221 0.86 RAB9A (0.39) NPC1RAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL25663199 0.84 CYP11B1 (0.35) NPC1RAB9ACYP3A4LIMK1CYP11B1
SCHEMBL25663200 0.84 GRM4 (0.36) NPC1RAB9ALIMK1CYP11B1MEN1
SCHEMBL24055864 0.82 NPC1 (0.42) NPC1RAB9ACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 NPC1 3859/4885RAB9A 2198/4885CYP3A4 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback